Formation Bio
New York, New York, United States · Artificial Intelligence, Biotechnology, Health Care
TrialSpark, a tech-driven drug developer with a portfolio of clinical stage drug assets, is rebranding to Formation Bio. Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial compl
Key facts
- Headquarters
- New York, New York, United States
- Employees
- 179
- Industries
- Artificial Intelligence, Biotechnology, Health Care
- Status
- Private
- Website
- formation.bio
- Company page
Recent activity at Formation Bio
- : Formation Bio Appoints Michael D. Ehlers as Chief Scientific Officer
- : Formation Bio Appoints Louis Brenner as Chief Medical Officer and Daniel Neil as Chief Technology Officer
- : TrialSpark
- : Formation Bio raised $372MM in a Series D funding led by a16z with participation from Sanofi and other investors
Formation Bio funding history
| Date | Round | Amount |
|---|---|---|
| Jul 2024 | Venture | $372.2M |
| Jun 2024 | Series D | $372.0M |
Leadership
- Dale Klasko, Vice President, People
- Michael D. Ehlers, Head of Research
- Emily Gransky, VP, Talent
- Daniel Neil, Chief Technology Officer
- Louis Brenner, Chief Medical Officer
- Benjamine Liu, Founder
- Linhao Zhang, Founder
Verified email and direct lines for Formation Bio’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Formation Bio in the news
- Anirvan Ghosh Joins Formation Bio as SVP, Head of Translational Sciences - PR Newswire (Oct 08, 2026)
- Biogen R&D vet gets in Formation—Chutes & Ladders - Fierce Biotech (Jul 24, 2026)
- Who is the CEO of Formation Bio in 2026? Benjamine Liu's Bio - Clay (Apr 15, 2026)
- Formation Bio Appoints Michael Ehlers as Chief Scientific Officer and Head of R&D - PR Newswire (Jul 22, 2026)
- Exclusive: Formation Bio looks to follow Abivax's success, licensing drug with same target from China - Endpoints News (Jan 29, 2026)
- This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Faster - Forbes (Apr 17, 2026)
- OverT Bio Announces the Formation of the Clinical Advisory Board to Support the Clinical Development of OVT-101 in Ovarian Cancer and Other Solid Tumors - Business Wire (Mar 23, 2026)
- Formation Bio's China shopping spree continues with $500M biobucks autoimmune pact - Fierce Biotech (Jan 29, 2026)
Companies similar to Formation Bio
- Protina · Artificial Intelligence, Biotechnology, Health Care, Pharmaceutical
- i'SUPPLY · Artificial Intelligence, Biotechnology, Health Care, Pharmaceutical
- Shuttle Pharmaceutical Holdings · Artificial Intelligence, Biotechnology, Health Care, Pharmaceutical
- Algorae Pharmaceuticals · Artificial Intelligence, Biotechnology, Health Care, Pharmaceutical
- Luminari CRO · Artificial Intelligence, Biotechnology, Health Care, Pharmaceutical
About Formation Bio: questions and answers
What does Formation Bio do?
TrialSpark, a tech-driven drug developer with a portfolio of clinical stage drug assets, is rebranding to Formation Bio. Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial compl
Where is Formation Bio headquartered?
Formation Bio is headquartered in New York, New York, United States.
How many employees does Formation Bio have?
Formation Bio has about 179 employees.
Has Formation Bio raised funding?
Yes. Fundz has recorded 2 funding events for Formation Bio. The most recent, $372.2M, was in Jul 2024.
Who leads Formation Bio?
Dale Klasko is a Vice President, People at Formation Bio.
What is the latest news on Formation Bio?
On Jul 22, 2026, Formation Bio Appoints Michael D. Ehlers as Chief Scientific Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy